SEC Form 4 · accession 0001209191-18-008621
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Donatiello Jr.
Director
Period of report
Feb 6, 2018
Accepted (ET)
Feb 8, 2018 · 8:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Feb 6, 2018 | A | 3,920 | $0.00 | A | 3,920 | D | |
| Class A Common StockF3 | Feb 6, 2018 | S | 200 | $60.6301 | D | 23,328 | I | By Nicholas Donatiello, Jr. Trustee of the Nicholas Donatiello, Jr. Trust u/a/d April 22, 2011 |
| Class A Common StockF4 | Feb 6, 2018 | S | 2,417 | $62.114 | D | 20,911 | I | By Nicholas Donatiello, Jr. Trustee of the Nicholas Donatiello, Jr. Trust u/a/d April 22, 2011 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Award represents a total of 3,920 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2019 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
- F2Shares held following the reported transactions include 3,920 restricted stock units, which are subject to forfeiture until they vest.
- F3This transaction was executed in multiple trades at prices ranging from $60.3201 to $60.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4This transaction was executed in multiple trades at prices ranging from $61.70 to $62.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Remarks
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.